Cargando…
Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension
Hypertension is one of the major adverse effects of tyrosine kinase inhibitors (TKIs) targeting vascular endothelial growth factors. However, the mechanism underlying TKIs-induced hypertension remains unclear. Here, we explored the role of the RhoA/Rho kinase (ROCK) signaling pathway in elevation of...
Autores principales: | Li, Caie, Ma, Liping, Wang, Qiongying, Shao, Xuejiao, Guo, Lu, Chen, Jianshu, Wang, Wenjuan, Yu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901036/ https://www.ncbi.nlm.nih.gov/pubmed/34862331 http://dx.doi.org/10.1097/HJH.0000000000003060 |
Ejemplares similares
-
Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer
por: Wang, Wenjuan, et al.
Publicado: (2022) -
Corrigendum: Research on the mechanism and prevention of hypertension caused by apatinib through the RhoA/ROCK signaling pathway in a mouse model of gastric cancer
por: Wang, Wenjuan, et al.
Publicado: (2022) -
Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023) -
A narrative review on the interaction between genes and the treatment of hypertension and breast cancer
por: Wang, Wenjuan, et al.
Publicado: (2021) -
Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
por: Fazakas, Csilla, et al.
Publicado: (2018)